Faruk Kurhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Faruk Kurhan has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Hamit Hakan Alp
Department of Biochemistry, Faculty of Medicine , Van Yuzuncu Yil University , Van , Türkiye
5 shared publications - Emine Fusun Akyuz Cim
Department of Psychiatry, Florence Nightingale Hospital, Medical Faculty Demiroglu Bilim University Istanbul Turkey
3 shared publications - Gülsüm Zuhal Kamış
Department of Psychiatry, Ankara Bilkent City Hospital, Ankara, Turkiye
3 shared publications - Abdullah Atli
Faculty of Medicine, Department of Psychiatry, Dicle University, Diyarbakir, Turkey
2 shared publications Gulsum Zuhal Kamis
Akhisar Mustafa Kirazoglu Devlet Hastanesi, Ruh Sagligi & Hastaliklari, Manisa, Turkey
2 shared publications- Ibrahim Halil Yavuz
Department of Dermatology, Başakşehir Çam and Sakura City Hospital, 34480 İstanbul, Türkiye
2 shared publications
Latest Publications
- 27 August 2026
- Published by Wolters Kluwer Health in The Journal of ECT
Electroconvulsive Therapy in a Longitudinal Transition From Early-Onset Obsessive-Compulsive Disorder to a Schizo-Obsessive Phenotype
Electroconvulsive therapy (ECT) is a well-established intervention for severe and treatment-resistant psychotic disorders; however, its domain-specific effectiveness across obsessive-compulsive and psychotic symptom dimensions within schizo-obsessive spectrum transitions is not well described. We report an 18-year-old female with severe childhood-onset obsessive-compulsive disorder (OCD) who, across adolescence, developed progressive insight erosion followed by referential delusions and tactile hallucinations. Across 3 consecutive hospitalizations, the clinical burden shifted from predominantly obsessive-compulsive pathology to psychosis-dominant symptomatology, prompting multimodal pharmacotherapy and repeated courses of ECT (total 12 sessions). Longitudinal symptom monitoring demonstrated partial and fluctuating improvement of obsessive-compulsive symptoms, while psychotic symptom severity showed marked and reproducible reduction following ECT courses, accompanied by global clinical improvement. This case highlights a clinically meaningful dissociation in treatment responsiveness, suggesting that ECT may preferentially ameliorate the psychotic dimension in schizo-obsessive spectrum presentations, whereas obsessive pathology may persist as residual burden, underscoring the importance of dimensional and stage-sensitive treatment planning.
- 27 August 2026
- Published by Wolters Kluwer Health in The Journal of ECT
Electroconvulsive Therapy in a Longitudinal Transition From Early-Onset Obsessive-Compulsive Disorder to a Schizo-Obsessive Phenotype
Electroconvulsive therapy (ECT) is a well-established intervention for severe and treatment-resistant psychotic disorders; however, its domain-specific effectiveness across obsessive-compulsive and psychotic symptom dimensions within schizo-obsessive spectrum transitions is not well described. We report an 18-year-old female with severe childhood-onset obsessive-compulsive disorder (OCD) who, across adolescence, developed progressive insight erosion followed by referential delusions and tactile hallucinations. Across 3 consecutive hospitalizations, the clinical burden shifted from predominantly obsessive-compulsive pathology to psychosis-dominant symptomatology, prompting multimodal pharmacotherapy and repeated courses of ECT (total 12 sessions). Longitudinal symptom monitoring demonstrated partial and fluctuating improvement of obsessive-compulsive symptoms, while psychotic symptom severity showed marked and reproducible reduction following ECT courses, accompanied by global clinical improvement. This case highlights a clinically meaningful dissociation in treatment responsiveness, suggesting that ECT may preferentially ameliorate the psychotic dimension in schizo-obsessive spectrum presentations, whereas obsessive pathology may persist as residual burden, underscoring the importance of dimensional and stage-sensitive treatment planning.
- 6 August 2026
- Published by Springer Nature in Ecohealth
- p. 1-2
Response to Comment on “Awareness and Anxiety Levels of Healthcare Workers Related to the Climate Crisis”
- 6 August 2026
- Published by Springer Nature in Ecohealth
- p. 1-2
Response to Comment on “Awareness and Anxiety Levels of Healthcare Workers Related to the Climate Crisis”
- 23 May 2026
- Published by Springer Nature in Ecohealth
Awareness and Anxiety Levels of Healthcare Workers related to the Climate Crisis
The climate crisis is not only an environmental issue but also a growing challenge to biopsychosocial well-being. This study examined the association between climate crisis awareness and mental health-related indicators, specifically eco-anxiety and depressive symptoms, among healthcare professionals. This cross-sectional study was conducted between June and September 2023 using an online survey in Türkiye. A total of 301 healthcare professionals-including physicians, psychologists, nurses, and allied health personnel-participated using snowball (non-probability) sampling. Data were collected using a sociodemographic questionnaire, the Beck Depression Inventory (BDI), the Ecological Awareness and Consciousness Scale (EACS), and the Eco-Anxiety Scale (EAS). The EACS was adapted from an existing instrument and applied for exploratory purposes. Statistical analyses were conducted using SPSS 25.0, employing nonparametric tests (Mann-Whitney U and Spearman's correlation). Results showed that 71.4% of participants were female and 28.6% were male, with a mean professional experience of 10.96 ± 6.9 years. Most participants (87%) reported being informed about climate change, primarily through media sources. Climate crisis awareness was positively correlated with eco-anxiety (r = 0.339, P < 0.001), and eco-anxiety was positively associated with depressive symptom severity (r = 0.482, P < 0.001). In secondary analyses, male participants reported higher levels of eco-anxiety and depressive symptoms than females (P < 0.01). These findings highlight the psychological correlates associated with climate crisis awareness among healthcare professionals and underscore the importance of integrating mental health support and resilience-building strategies into climate-related education and awareness initiatives. Given the cross-sectional design, the findings reflect associations rather than causal effects.
- 23 May 2026
- Published by Springer Nature in Ecohealth
Awareness and Anxiety Levels of Healthcare Workers related to the Climate Crisis
The climate crisis is not only an environmental issue but also a growing challenge to biopsychosocial well-being. This study examined the association between climate crisis awareness and mental health-related indicators, specifically eco-anxiety and depressive symptoms, among healthcare professionals. This cross-sectional study was conducted between June and September 2023 using an online survey in Türkiye. A total of 301 healthcare professionals-including physicians, psychologists, nurses, and allied health personnel-participated using snowball (non-probability) sampling. Data were collected using a sociodemographic questionnaire, the Beck Depression Inventory (BDI), the Ecological Awareness and Consciousness Scale (EACS), and the Eco-Anxiety Scale (EAS). The EACS was adapted from an existing instrument and applied for exploratory purposes. Statistical analyses were conducted using SPSS 25.0, employing nonparametric tests (Mann-Whitney U and Spearman's correlation). Results showed that 71.4% of participants were female and 28.6% were male, with a mean professional experience of 10.96 ± 6.9 years. Most participants (87%) reported being informed about climate change, primarily through media sources. Climate crisis awareness was positively correlated with eco-anxiety (r = 0.339, P < 0.001), and eco-anxiety was positively associated with depressive symptom severity (r = 0.482, P < 0.001). In secondary analyses, male participants reported higher levels of eco-anxiety and depressive symptoms than females (P < 0.01). These findings highlight the psychological correlates associated with climate crisis awareness among healthcare professionals and underscore the importance of integrating mental health support and resilience-building strategies into climate-related education and awareness initiatives. Given the cross-sectional design, the findings reflect associations rather than causal effects.
- Open Access
- 24 March 2026
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 24 (4) , 809-820
NADPH Oxidase–driven Oxidative Profile in Adult Attention-deficit/Hyperactivity Disorder: NOX2/NOX4 Activation and Lipid Peroxidation
Gülsüm Zuhal Kamış, Faruk Kurhan, Hamit Hakan Alp. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.26.1417
- 24 March 2026
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 24 (4) , 809-820
Open AccessNADPH Oxidase–driven Oxidative Profile in Adult Attention-deficit/Hyperactivity Disorder: NOX2/NOX4 Activation and Lipid Peroxidation
Gülsüm Zuhal Kamış, Faruk Kurhan, Hamit Hakan Alp. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.26.1417
- Open Access
- 30 November 2025
- Published by SAGE Publications in Journal of Health Psychology
- Vol. 31 (7) , 2928-2937
The hidden burden of visibility: Social appearance anxiety in patients with alopecia areata – A comparative cross-sectional study
This cross-sectional study investigated social appearance anxiety in individuals with Alopecia Areata (AA), a chronic autoimmune condition causing visible, non-scarring hair loss. A total of 129 AA patients and 142 age- and sex-matched healthy controls (18–65 years) completed the Social Appearance Anxiety Scale (SAAS) and the Hospital Anxiety and Depression Scale (HADS); the AA group additionally completed the Dermatology Life Quality Index (DLQI) and a Visual Analog Scale (VAS). SAAS scores were markedly higher in AA than controls (65.32 ± 8.45 vs 21.45 ± 9.32, p < 0.001). Within AA, SAAS showed a moderate positive association with perceived severity (VAS; r = 0.304, p < 0.05). HADS-Anxiety/Depression did not differ significantly between groups. In the AA cohort, DLQI averaged 12.3 ± 5.4 (median 12, IQR 9–16), with 62.8% ⩾ 10 and 10.9% ⩾ 20. DLQI correlated most strongly with perceived severity (VAS; r = 0.45, p < 0.001) and clinical visibility ( r = 0.37, p = 0.002), with comparatively smaller associations with lesion count/area ( r = 0.26/0.34). Taken together, these findings indicate that AA’s psychosocial burden is driven primarily by appearance- and visibility-related factors rather than generalized anxiety/depression or sheer disease extent. Routine dermatologic care should incorporate targeted psychosocial assessment—particularly for patients with visible-site involvement—to facilitate timely support.
- 30 November 2025
- Published by SAGE Publications in Journal of Health Psychology
- Vol. 31 (7) , 2928-2937
Open AccessThe hidden burden of visibility: Social appearance anxiety in patients with alopecia areata – A comparative cross-sectional study
This cross-sectional study investigated social appearance anxiety in individuals with Alopecia Areata (AA), a chronic autoimmune condition causing visible, non-scarring hair loss. A total of 129 AA patients and 142 age- and sex-matched healthy controls (18–65 years) completed the Social Appearance Anxiety Scale (SAAS) and the Hospital Anxiety and Depression Scale (HADS); the AA group additionally completed the Dermatology Life Quality Index (DLQI) and a Visual Analog Scale (VAS). SAAS scores were markedly higher in AA than controls (65.32 ± 8.45 vs 21.45 ± 9.32, p < 0.001). Within AA, SAAS showed a moderate positive association with perceived severity (VAS; r = 0.304, p < 0.05). HADS-Anxiety/Depression did not differ significantly between groups. In the AA cohort, DLQI averaged 12.3 ± 5.4 (median 12, IQR 9–16), with 62.8% ⩾ 10 and 10.9% ⩾ 20. DLQI correlated most strongly with perceived severity (VAS; r = 0.45, p < 0.001) and clinical visibility ( r = 0.37, p = 0.002), with comparatively smaller associations with lesion count/area ( r = 0.26/0.34). Taken together, these findings indicate that AA’s psychosocial burden is driven primarily by appearance- and visibility-related factors rather than generalized anxiety/depression or sheer disease extent. Routine dermatologic care should incorporate targeted psychosocial assessment—particularly for patients with visible-site involvement—to facilitate timely support.
- 24 October 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (3) , 387-392
The impact of facial vitiligo on social appearance anxiety: a case–control study
Background: Vitiligo, particularly when involving the face, is associated not only with visible disfigurement but also with profound psychosocial consequences. Despite growing interest in the psychosomatic dimensions of skin diseases, the relationship between facial vitiligo and social appearance anxiety remains underexplored. Objectives: To evaluate the level of social appearance anxiety in patients with facial vitiligo and to compare it with healthy controls. Further, to examine how this anxiety correlates with broader psychological and quality-of-life parameters. In addition, we conducted secondary analyses, including subgroup comparisons based on facial lesion location, and moderation analysis using general anxiety as a moderator. Methods: A cross-sectional case–control study was conducted among 156 patients with nonsegmental facial vitiligo and 143 demographically matched healthy controls. All participants completed the Social Appearance Anxiety Scale (SAAS) and the Hospital Anxiety and Depression Scale (HADS). Patients with vitiligo additionally completed the Dermatology Life Quality Index and a visual analogue scale assessing perceived disease severity. Facial lesion regions were classified anatomically (forehead, periorbital, perioral, mandibular) for subgroup analysis. Moderation analysis was performed to examine whether general anxiety (HADS-Anxiety) moderated the relationship between lesion visibility and SAAS scores. Results: SAAS scores were markedly higher in the group with vitiligo (mean 55.2, SD 9.2) than in controls (mean 19.7, SD 8.4), with a large effect size (Cohen’s d = 4.16; P < 0.001). In patients with vitiligo, SAAS scores were significantly correlated with anxiety (r = 0.75), depression (r = 0.50), quality-of-life impairment (r = 0.41) and perceived severity (r = 0.61); all P < 0.01. Subgroup analysis revealed significantly higher SAAS scores among patients with periorbital and perioral involvement than in those with mandibular or isolated forehead lesions (P < 0.05). Moderation analysis confirmed that the strength of association between lesion location and SAAS was significantly amplified in patients with high HADS-A scores (interaction term P < 0.01). Conclusions: Facial vitiligo imposes a substantial psychological burden, characterized by elevated social appearance anxiety that extends beyond general psychopathology. Our findings suggest that specific lesion sites, particularly periorbital and perioral areas, are more psychologically distressing and that general anxiety amplifies this impact. These results underscore the need for tailored psychosocial support depending on lesion location and baseline anxiety levels.
- 24 October 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (3) , 387-392
The impact of facial vitiligo on social appearance anxiety: a case–control study
Background: Vitiligo, particularly when involving the face, is associated not only with visible disfigurement but also with profound psychosocial consequences. Despite growing interest in the psychosomatic dimensions of skin diseases, the relationship between facial vitiligo and social appearance anxiety remains underexplored. Objectives: To evaluate the level of social appearance anxiety in patients with facial vitiligo and to compare it with healthy controls. Further, to examine how this anxiety correlates with broader psychological and quality-of-life parameters. In addition, we conducted secondary analyses, including subgroup comparisons based on facial lesion location, and moderation analysis using general anxiety as a moderator. Methods: A cross-sectional case–control study was conducted among 156 patients with nonsegmental facial vitiligo and 143 demographically matched healthy controls. All participants completed the Social Appearance Anxiety Scale (SAAS) and the Hospital Anxiety and Depression Scale (HADS). Patients with vitiligo additionally completed the Dermatology Life Quality Index and a visual analogue scale assessing perceived disease severity. Facial lesion regions were classified anatomically (forehead, periorbital, perioral, mandibular) for subgroup analysis. Moderation analysis was performed to examine whether general anxiety (HADS-Anxiety) moderated the relationship between lesion visibility and SAAS scores. Results: SAAS scores were markedly higher in the group with vitiligo (mean 55.2, SD 9.2) than in controls (mean 19.7, SD 8.4), with a large effect size (Cohen’s d = 4.16; P < 0.001). In patients with vitiligo, SAAS scores were significantly correlated with anxiety (r = 0.75), depression (r = 0.50), quality-of-life impairment (r = 0.41) and perceived severity (r = 0.61); all P < 0.01. Subgroup analysis revealed significantly higher SAAS scores among patients with periorbital and perioral involvement than in those with mandibular or isolated forehead lesions (P < 0.05). Moderation analysis confirmed that the strength of association between lesion location and SAAS was significantly amplified in patients with high HADS-A scores (interaction term P < 0.01). Conclusions: Facial vitiligo imposes a substantial psychological burden, characterized by elevated social appearance anxiety that extends beyond general psychopathology. Our findings suggest that specific lesion sites, particularly periorbital and perioral areas, are more psychologically distressing and that general anxiety amplifies this impact. These results underscore the need for tailored psychosocial support depending on lesion location and baseline anxiety levels.
- Open Access
- 23 October 2025
- Published by Taylor & Francis in Biological Rhythm Research
- Vol. 57 (4) , 267-281
Sleep, rhythm, and mental burden: disruption of psychobiological balance in patients with myasthenia gravis
- 23 October 2025
- Published by Taylor & Francis in Biological Rhythm Research
- Vol. 57 (4) , 267-281
Open AccessSleep, rhythm, and mental burden: disruption of psychobiological balance in patients with myasthenia gravis
- 22 May 2025
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 26 (6) , 224-233
Evaluation of retinal layer thickness in patients with bipolar disorder, their relatives, and healthy controls using optical coherence tomography
Bipolar disorder (BD) is a chronic psychiatric condition characterised by mood episodes and associated structural changes in the central nervous system. Optical coherence tomography (OCT) offers a non-invasive method to assess retinal layer thickness, potentially serving as an endophenotypic biomarker for neurodegeneration. This study aimed to compare retinal thickness among BD patients, their first-degree relatives, and healthy controls to identify structural markers and assess their alignment with existing literature. Thirty-six BD patients, 30 first-degree relatives, and 38 healthy controls were recruited from Van Yüzüncü Yıl University. Comprehensive ophthalmologic examinations and retinal layer thickness measurements using Spectralis OCT were performed. Retinal layers were analysed at 1 mm, 3 mm, and 6 mm concentric circles per the ETDRS protocol. Peripapillary retinal nerve fibre layer (RNFL) thickness was evaluated across seven regions. Due to significant age differences among groups (p = 0.002), an ANCOVA analysis was used to control for the age effect. Retinal analysis revealed a significant increase in the inferonasal (NI) nerve fibre layer thickness in BD patients and their first-degree relatives compared to healthy controls (p = 0.008). Optic nerve head analyses showed non-significant thinning in the temporal (T), inferotemporal (TI), and superotemporal (TS) nerve fibre layer thicknesses in BD patients and their relatives compared to healthy controls. The thicknesses of the macular retinal layers did not differ significantly among the groups (p > 0.05). The observed increase in NI optic nerve fibre layer thickness in BD patients and their first-degree relatives contrasts with the expected thinning reported in previous literature on neurodegeneration in psychiatric disorders. This finding underscores the complexity of structural changes in BD and raises the possibility of alternative pathophysiological mechanisms or methodological considerations influencing retinal measurements. Further research is needed to elucidate these phenomena and their implications for understanding BD.
- 22 May 2025
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 26 (6) , 224-233
Evaluation of retinal layer thickness in patients with bipolar disorder, their relatives, and healthy controls using optical coherence tomography
Bipolar disorder (BD) is a chronic psychiatric condition characterised by mood episodes and associated structural changes in the central nervous system. Optical coherence tomography (OCT) offers a non-invasive method to assess retinal layer thickness, potentially serving as an endophenotypic biomarker for neurodegeneration. This study aimed to compare retinal thickness among BD patients, their first-degree relatives, and healthy controls to identify structural markers and assess their alignment with existing literature. Thirty-six BD patients, 30 first-degree relatives, and 38 healthy controls were recruited from Van Yüzüncü Yıl University. Comprehensive ophthalmologic examinations and retinal layer thickness measurements using Spectralis OCT were performed. Retinal layers were analysed at 1 mm, 3 mm, and 6 mm concentric circles per the ETDRS protocol. Peripapillary retinal nerve fibre layer (RNFL) thickness was evaluated across seven regions. Due to significant age differences among groups (p = 0.002), an ANCOVA analysis was used to control for the age effect. Retinal analysis revealed a significant increase in the inferonasal (NI) nerve fibre layer thickness in BD patients and their first-degree relatives compared to healthy controls (p = 0.008). Optic nerve head analyses showed non-significant thinning in the temporal (T), inferotemporal (TI), and superotemporal (TS) nerve fibre layer thicknesses in BD patients and their relatives compared to healthy controls. The thicknesses of the macular retinal layers did not differ significantly among the groups (p > 0.05). The observed increase in NI optic nerve fibre layer thickness in BD patients and their first-degree relatives contrasts with the expected thinning reported in previous literature on neurodegeneration in psychiatric disorders. This finding underscores the complexity of structural changes in BD and raises the possibility of alternative pathophysiological mechanisms or methodological considerations influencing retinal measurements. Further research is needed to elucidate these phenomena and their implications for understanding BD.